ORIB 10-K & 10-Q changes, risk factors and insider trading
Orion Bliss Corp. · OTC · Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics · CIK 1854183 · All filings on SEC.gov
At a glance
What changed in the latest 10-K
Risk Factors
Not required for Smaller reporting companies.
No wording changes found in this section.
Full comparison: every changed paragraph (0)
Management's Discussion & Analysis (MD&A)
Largest changes
We have not generated cash flows from investing activities during the year ended April 30, 2026 We have not generated positive cash flows from investingsee in full comparisonactivities.activities during the year ended April 30, 2025. For the year ended April 30, 2025 we used $45,500 in investing activities.
Full comparison: every changed paragraph (1)
We have not generated cash flows from investing activities during the
year ended April 30, 2026 We have not generated positive cash flows from
investing activities.activities during the year ended April 30, 2025. For the year ended April 30,
2025 we used $45,500 in investing activities.
What changed in the latest 10-Q
Risk Factors
We could not find a separate Risk Factors item in the latest 10-Q. Some companies leave it out of quarterly reports; see the annual 10-K risk factors and the original filing. Open the filing on SEC.gov.
Management's Discussion & Analysis (MD&A)
Largest changes
As ofsee in full comparisonJanuaryJuly 31, 2026, our total assets were $37,319$36,644consisting of website development, net of $134, mobile application $45,500, cash$2,385$7,610 from issuance of common stock and accumulated amortization$11,375.$15,925. As ofJanuaryJuly 31, 2026, our current liabilities were$177,043$185,986 consisting of accounts payable-related party advances of$58,000,$64,000, director loan of$67,853,$68,520, note payable of $45,500 and interest payable$5,690.$7,966.
“We have generated positive cash flows from operating activities. For the nine months ended January 31, 2025, net cash flows used in operating activities were $32,321.”see in full comparison
“Our net loss for the three and nine months ended January 31, 2026 was $18,085 and $36,503. Operating expenses consist of mainly professional fees.”see in full comparison
“Our net loss for the three months ended July 31, 2025 was $11,522. Operating expenses consist of mainly professional fees.”see in full comparison
“During the three and nine months ended January 31, 2025 the Company has generated $8,765 and $14,765 revenue.”see in full comparison
We have generated positive cash flows from financing activities in the amountsee in full comparison$3,543$4,138 during theninethree months endedJanuaryJuly 31, 2026. During theninethree months endedJanuaryJuly 31, 2025 we generated positive cash flows from financing activities of$23,550.$1,138.
Full comparison: every changed paragraph (11)
Three Months Ended JanuaryJuly 31, 2026 and 2025:
During the three and nine months ended January
July 31, 2026 the
Company has generated $0 and $6,000$12,000 revenue.
Our net loss for the three and nine months ended
January 31, 2026 was $18,085 and $36,503. Operating expenses consist of mainly professional fees.
During the three and nine months ended January
31, 2025 the Company has generated $8,765 and $14,765 revenue.
Our net loss for the three and nine months ended
January July 31, 2025
2026 was $1,043 and $15,454.$3,844. Operating expenses consist of mainly professional fees.
During the three months ended July 31, 2025 the Company has generated $3,000 revenue.
Our net loss for the three months ended July 31, 2025 was $11,522. Operating expenses consist of mainly professional fees.
As of JanuaryJuly 31, 2026, our total assets were $37,319
$36,644 consisting of website development, net of $134, mobile application $45,500, cash $2,385$7,610 from issuance of common stock and accumulated
amortization $11,375.$15,925. As of JanuaryJuly 31, 2026, our current liabilities were $177,043$185,986 consisting of accounts payable-related party advances
of $58,000,$64,000, director loan of $67,853,$68,520, note payable of $45,500 and interest payable $5,690.$7,966.
We have not generated positive cash flows from
operating activities. For the ninethree months ended JanuaryJuly 31, 2026,2026 and 2025, net cash flows used in operating activities were $20,678.$1,569 and $6,247.
We have generated positive cash flows from operating
activities. For the nine months ended January 31, 2025, net cash flows used in operating activities were $32,321.
We have generated positive cash flows from financing
activities in the amount $3,543$4,138 during the ninethree months ended JanuaryJuly 31, 2026. During the ninethree months ended JanuaryJuly 31, 2025 we generated
positive cash flows from financing activities of $23,550.$1,138.
ORIB insider buying and selling (Form 4)
Since 2026-04-11, insiders reported open-market purchases in 0 Form 4 filings and open-market sales in 0 filings. Totals add up every open-market (code P and S) line in those filings, using the prices reported in the filings. Awards, option exercises, tax withholding and gifts are listed below but not counted.
No Form 4 stock transactions in this period.
Well-known investors holding ORIB (13F)
None of the 59 investors we track reported a position in their latest 13F.